Celanese Corporation Files Definitive Proxy Statement

Ticker: CE · Form: DEF 14A · Filed: Mar 21, 2024 · CIK: 1306830

Celanese CORP DEF 14A Filing Summary
FieldDetail
CompanyCelanese CORP (CE)
Form TypeDEF 14A
Filed DateMar 21, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$10,940 m, $18, $8.92, $1,960 million, $2,444 million
Sentimentneutral

Sentiment: neutral

Topics: Proxy Statement, Celanese Corporation, SEC Filing, DEF 14A, Corporate Governance

TL;DR

<b>Celanese Corporation has filed its Definitive Proxy Statement for the 2023 fiscal year.</b>

AI Summary

Celanese Corp (CE) filed a Proxy Statement (DEF 14A) with the SEC on March 21, 2024. Celanese Corporation filed a Definitive Proxy Statement on March 21, 2024. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal executive offices are located at 222 W. Las Colinas Blvd., Suite 900N, Irving, TX 75039-5421. The filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934. Celanese Corporation is incorporated in Delaware.

Why It Matters

For investors and stakeholders tracking Celanese Corp, this filing contains several important signals. This filing is a standard requirement for publicly traded companies to inform shareholders about upcoming meetings and voting matters. It provides details on executive compensation, board nominations, and other corporate governance issues that shareholders will vote on.

Risk Assessment

Risk Level: low — Celanese Corp shows low risk based on this filing. The filing is a routine proxy statement, indicating no immediate material changes or significant events requiring a higher risk assessment.

Analyst Insight

Review the proxy statement for details on executive compensation, board proposals, and shareholder voting items to understand potential impacts on corporate governance and strategy.

Key Numbers

Key Players & Entities

FAQ

When did Celanese Corp file this DEF 14A?

Celanese Corp filed this Proxy Statement (DEF 14A) with the SEC on March 21, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Celanese Corp (CE).

Where can I read the original DEF 14A filing from Celanese Corp?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Celanese Corp.

What are the key takeaways from Celanese Corp's DEF 14A?

Celanese Corp filed this DEF 14A on March 21, 2024. Key takeaways: Celanese Corporation filed a Definitive Proxy Statement on March 21, 2024.. The filing covers the period from January 1, 2023, to December 31, 2023.. The company's principal executive offices are located at 222 W. Las Colinas Blvd., Suite 900N, Irving, TX 75039-5421..

Is Celanese Corp a risky investment based on this filing?

Based on this DEF 14A, Celanese Corp presents a relatively low-risk profile. The filing is a routine proxy statement, indicating no immediate material changes or significant events requiring a higher risk assessment.

What should investors do after reading Celanese Corp's DEF 14A?

Review the proxy statement for details on executive compensation, board proposals, and shareholder voting items to understand potential impacts on corporate governance and strategy. The overall sentiment from this filing is neutral.

How does Celanese Corp compare to its industry peers?

Celanese Corporation operates in the chemical industry, focusing on producing and selling specialty materials used in various industrial and consumer applications.

Are there regulatory concerns for Celanese Corp?

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

Industry Context

Celanese Corporation operates in the chemical industry, focusing on producing and selling specialty materials used in various industrial and consumer applications.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

What Investors Should Do

  1. Review the executive compensation details for key executives.
  2. Analyze the proposals to be voted on by shareholders.
  3. Examine any director nominations and committee reports.

Key Dates

Year-Over-Year Comparison

This is the initial filing of the Definitive Proxy Statement for the 2023 fiscal year, following the previous year's filings.

Filing Stats: 4,540 words · 18 min read · ~15 pages · Grade level 14.2 · Accepted 2024-03-21 16:47:31

Key Financial Figures

Filing Documents

: ELECTION OF DIRECTORS

ITEM 1: ELECTION OF DIRECTORS 11 Director Nominees 14 Board and Committee Governance 24 Board Oversight 32 Shareholder Engagement 37 Additional Governance Matters 37 Director Compensation 39 Director Independence and Related Person Transactions 41 STOCK OWNERSHIP INFORMATION 44 Principal Shareholders and Beneficial Owners 44 Delinquent Section 16(a) Reports 46 Securities Authorized for Issuance Under Equity Compensation Plans 46 AUDIT MATTERS 47 Audit Committee Report 47

: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

ITEM 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 48

EXECUTIVE COMPENSATION* 50

EXECUTIVE COMPENSATION* 50

: ADVISORY APPROVAL OF EXECUTIVE COMPENSATION

ITEM 3: ADVISORY APPROVAL OF EXECUTIVE COMPENSATION 51 Compensation Discussion and Analysis 52 Compensation Risk Assessment 73 Compensation and Management Development Committee Report 74 Compensation Tables 75 CEO Pay Ratio 89 Pay Versus Performance 90 MANAGEMENT PROPOSAL 94 ITEM 4: APPROVAL OF THE AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO PROVIDE FOR OFFICER EXCULPATION AND INDEMNIFICATION UNDER DELAWARE LAW 94 QUESTIONS AND ANSWERS 97 Annual Meeting Information 97 Proxy Materials and Voting Information 99 Company Documents, Communications and Shareholder Proposals 102 EXHIBIT A A-1 Non-U.S. GAAP Financial Measures A-1 *Detailed table of contents for compensation topics on page 50 . Cautionary Note Regarding Forward-Looking Statements; Available Information This Proxy Statement includes estimates, projections, statements relating to our business plans, objectives, and expected operating results that are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this Proxy Statement. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that may cause actual results to differ materially. We describe risks and uncertainties that could cause actual results and events to differ materially in "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our Forms 10-K and 10-Q. We undertake no obligation to update or revi

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing